Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.

Reset all filters
01 1Curia
02 1Shandong Chenghui Shuangda Pharmaceutical
03 1Maithri Drugs
04 1ApiSyn
05 1Saiming Pharmaceutical
06 1Lianhe Chemical Technology
07 1Blank
Reset all filters
01 3China
02 2India
03 1U.S.A
04 1Blank
Reset all filters
01 7Blank
01 7Blank
Reset all filters
01 7Blank
Reset all filters
01 7Blank
Reset all filters
01 1Su196-35-ND
02 6Blank
Reset all filters
01 176047-003
02 6Blank
01 7Blank
Curia - Accelerating therapies from discovery to commercialization with flexible, scalable CDMO solutions.
China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress
Saiming Pharmaceutical – Delivering innovative, sustainable chemical solutions with global reach and 12+ years of trusted excellence.
NDC Package Code : 76047-003
Start Marketing Date : 2025-09-30
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (18kg/18kg)
Marketing Category : BULK INGREDIENT

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
Registrant Name : Novartis Korea
Registration Date : 2026-04-14
Registration Number : Su196-35-ND
Manufacturer Name : Lianhe Aigen Pharma Co., Ltd.
Manufacturer Address : No.3 Donghai 8th Avenue, Toumengang New District, Linhai, Taizhou, Zhejiang, 317016, China

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
17
PharmaCompass offers a list of Remibrutinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Remibrutinib manufacturer or Remibrutinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Remibrutinib manufacturer or Remibrutinib supplier.
A Remibrutinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Remibrutinib, including repackagers and relabelers. The FDA regulates Remibrutinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Remibrutinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Remibrutinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Remibrutinib supplier is an individual or a company that provides Remibrutinib active pharmaceutical ingredient (API) or Remibrutinib finished formulations upon request. The Remibrutinib suppliers may include Remibrutinib API manufacturers, exporters, distributors and traders.
click here to find a list of Remibrutinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
We have 6 companies offering Remibrutinib
Get in contact with the supplier of your choice: